By 2050, the number of individuals affected by stroke is expected to double. Although advances in the management of stroke have reduced stroke-related deaths, many survivors subsequently struggle with disabilities and decline in cognitive health. Dr. Waziry will develop biological age measurements assessed through a routine blood test to study whether biological age can help predict cognitive outcomes for stroke survivors. This project will also help researchers learn more about racial disparities in stroke risk and outcomes.
This research is funded by the McKnight Brain Research Foundation through the American Brain Foundation and the American Academy of Neurology. Dr. Waziry will conduct her research through Columbia University Medical Center.